News

On September 16th, myMatrixx parent company Cigna announced the launch of a new brand for its growing portfolio of high-performing health services. Evernorth was created to accelerate delivery of flexible solutions to meet the diverse needs of health plans, employers and government organizations....

Qdolo ™ (tramadol – Athena Bioscience) oral solution, 5mg/mL was approved on Sept. 1, 2020, by the U.S. Food and Drug Administration (FDA). A C-IV controlled substance, it is indicated for treating adults who have severe pain that requires an opioid, but that does not respond to other treatments....

In a new Work Comp Wire article, Chief Sales Officer David Dubrof discusses how strong pharmacy network relationships and clinical oversight are more important for a long-term claims management strategy. Newly appointed myMatrixx Chief Sales Officer, David Dubrof, was featured in the most recent...

myMatrixx, an Express Scripts Company today announced that David Dubrof has been named Chief Sales Officer for the organization. “We’re absolutely thrilled to have David join our team,” said Mike Cirillo, President of myMatrixx. “His 25-plus years of executive management experience in sales,...

Medical marijuana use continues to be a topic of debate in the workers’ compensation space, with states reviewing its legality and industry professionals trying to better understand its utility as a treatment. Recently, myMatrixx Chief Clinical Officer, Phil Walls, was quoted in an article for ...

myMatrixx assembles a panel of leading industry experts to discuss the impact of COVID-19 on workers' compensation in a virtual presentation for the Express Scripts Outcomes Summer Series.

During June and July, the FDA has issued a series of warnings that some commercial hand sanitizers contain methanol and it has asked a number of manufacturers to recall their products. Also known as wood alcohol, methanol is intended for industrial use in products such as pesticides and solvents....

In a Safety Communication on July 23, 2020, the FDA alerted prescribers, pharmacies and patients of a new requirement for opioid drugs. It is directing drug companies that make opioids for pain relief and for use in treating opioid use disorder to add information on the labels about the use of naloxone....

myMatrixx President, Mike Cirillo, and Chief Clinical Officer, Phil Walls, were recently quoted in an article for the Workers’ Compensation Institute (WCI). Due to the COVID-19 pandemic, WCI will be holding its annual conference virtually this year and are highlighting the sponsors, including myMatrixx,...

Expert’s View is a regular feature on WorkersCompensation.com that shares insights and opinions from leaders and stakeholders in the workers’ comp industry. After the launch of the 2019 myMatrixx Drug Trend Report , our Chief Clinical Officer, Phil Walls, published an article detailing some of...